Professor Seungpyo Hong continues to advance technology to track circulating tumor cells, which could lead to a more effective, easier way to monitor cancer progression.
Seungpyo Hong
School of Pharmacy Professor and Alum Receive Top Honor for Medical and Biological Engineers
Professor Seungpyo Hong and alumna Heidi Mansour are selected for their contributions to nanotechnology and pulmonary disease treatment.
$1M Grant Propels Inhalable Nanomedicine Research
With new funding from the Falk Medical Trust, Professor Seungpyo Hong and Allan Brasier, executive director of the UW Institute for Clinical and Translational Research, are paving the way for a novel treatment for idiopathic pulmonary fibrosis.
School of Pharmacy Faculty Host Five Global Scholars
Researchers from around the world visit the School to research antimicrobial resistance, cancer diagnostics and therapeutics, and pharmacy history By Katie Ginder-Vogel The University of Wisconsin–Madison is world-renowned for its research enterprise, ranking consistently among …
Grant Fuels Development of Inhalable Nanomedicine for Lung Diseases
With funding from the Discovery to Product program, Professor Seungpyo Hong and his collaborators are accelerating their research on idiopathic pulmonary fibrosis.
School Launches New Nanotechnology Center for Drug Delivery
Professors Seungpyo Hong, Sandro Mecozzi, Lingjun Li and Glen Kwon are combining their expertise to create a new research center that will improve the efficacy of new drug leads.
NSF Grant Fuels Professor Seungpyo Hong’s Cancer-Fighting Research
A new three-year grant from the National Science Foundation will support Professor Seungpyo Hong’s research into improving the efficacy of chemotherapies.
Improved Capture of Cancer Cells in Blood Could Help Track Disease
New research by Professor Seungpyo Hong and his collaborators demonstrates improved methods for capturing circulating tumor cells on clinical samples for the first time.
Improving Cancer Diagnosis and Treatment
Two professors at the UW–Madison School of Pharmacy’s Pharmaceutical Sciences Division are up for the challenge of being both entrepreneurs and academic researchers, and they’re both targeting cancer.
University of Wisconsin–Madison and Capio Biosciences Collaborate on Pharmaceutical Sciences Research
Capio Biosciences, Inc., a cancer diagnostic biotech startup, is partnering with the University of Wisconsin–Madison on research that will further develop novel technology in cancer detection. The Research Service Agreement (RSA) will support the research of …